Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trialP. Comella, G. Comella, Francovito Piantedosi et al.|Lung Cancer|2000Cited by 16
Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II studyCesare Gridelli, Luigi Manzione, S. Cigolari et al.|Lung Cancer|2000Cited by 7
Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trialS. Mancarella, M. De Lena, Vito Lorusso et al.|European Journal of Cancer|1999Cited by 4
Multicenter observational study on adherence and acceptance of lapatinib treatment in patients with HER2+ metastatic breast cancer.Raffaele Addeo, S. Del Prete, Bruno Vincenzi et al.|Journal of Clinical Oncology|2011Cited by 2
Anemia management with epoetin beta in anemic patients with cancer receiving chemotherapy: Pananemia observational study on clinical practice.Salvatore Del Prete, Raffaele Addeo, Franco Vito Piantedosi et al.|Journal of Clinical Oncology|2011Cited by 0